HSPA5 and COVID-19: Although one study showed that there was no significant difference in the severity of COVID-19 in cancer patients, as a receptor of SARS-Cov-2 31, dysregulation of HSPA5 expression in cancer patients' tissues, particularly in the lungs, should affect the susceptibility and severity of this virus infection.